当前位置: 首页 > 期刊 > 《中国临床实用医学》 > 2010年第12期 > 正文
编号:12013823
金水宝胶囊对慢性肾脏病患者血清胱抑素C与超敏C反应蛋白的影响(1)
http://www.100md.com 2010年12月1日 马西臣 谭玉利 顾海东
第1页

    参见附件(1522KB,2页)。

     【摘要】 目的 观察金水宝胶囊对慢性肾脏病(CKD)患者血清胱抑素C(Cystatin C)与超敏C反应蛋白(hsCRP)的影响。方法 34例明确诊断CKD患者,随机分为对照组(17例)和治疗组(17例),同时选择17名健康成人作为正常对照组,在基础治疗上加用金水宝胶囊3次/d,6粒/次口服,治疗前、后8周分别检测Cystatin C、hsCRP、Scr、BUN。结果 CKD患者Cystatin C、hsCRP、Scr较正常对照组明显增高(P<0.05),常规治疗8周后其Cystatin C、hsCRP、Scr有所降低,但差异无统计学意义(P>0.05),而加用金水宝胶囊治疗后其Cystatin C、hsCRP、Scr明显降低(P<0.05);Cystatin C与hsCRP呈正相关,Cystatin C与GFR呈负相关。结论 金水宝胶囊可改善早期CKD患者的肾功能和炎症状态,有利于延缓CKD的进展。 

    【关键词】 金水宝胶囊;慢性肾脏病;胱抑素C;超敏C反应蛋白

    Influence of jinshuibao capsule on serum cystatin C and high sensitive Creactive protein in chronic kidney disease patients

    MA Xichen, TAN Yuli, GU haidong

    .Department of Nephrology, the Affiliated Rizhao Hospital of Jining Medical College, Rizhao 276800,China

    【Abstract】 Objective To observe the influence of jinshuibao capsule on serum cystatin C and high sensitive Creactive(hsCRP)protein in chronic kidney disease patients(CKD).Methods Thirtyfour cases CKD patients were randomly divided into two groups:control group(17 cases)and treatment group(treatment with jinshuibao capsules, 17 cases). Meanwhile, 17 healthy adults were taken as the normal control. The blood concentrations of cystatin C,hsCRP,Scr and BUN were determined. Results The level of cystatin C,hsCRP,Scr in all CKD patients were significantly higher than those in the normal control(P<0.05), the level of cystatin C,hsCRP,Scr decreased after 8 weeks of conventional treatment(P>0.05), while those significantly decreased addition of jinshuibao capsule treatment(P<0.05); Cystatin C and hsCRP were positively correlated,but Cystatin C was negatively correlated with GFR. Conclusion The renal function and inflammation can be alleviated by jinshuibao capsule in early CKD patients, which could be slowed the progression of CKD.

    【Key words】 Jinshuibao capsule; Chronic kidney disease; Cystatin C; CRP

    CKD的防治已经成为世界各国所面临的重要公共卫生问题,早期发现CKD并采用适当的措施减慢GFR下降率,有利于延缓CKD的进展。研究表明Cystatin C与GFR有良好的相关性,因此有望成为替代Scr、Ccr的一种可反映GFR的理想标志物。大量研究证实CKD患者存在炎症因子的轻微而持续的活化[1],C反应蛋白(CRP)是急性时相蛋白,用超敏的方法测出较低浓度的CRP为hsCRP,是全身炎症的非特异性标志物。

    中医学认为冬虫夏草具有“补益肺肾、秘精益气”之功效,临床上可用于保护肾功能,延缓肾衰进展。金水宝胶囊为发酵虫草菌粉 ......

您现在查看是摘要介绍页,详见PDF附件(1522KB,2页)